Secondary Logo

Journal Logo

February 2011 - Volume 34 - Issue 1
pp: 1-109


Cutaneous


Gynecologic


Experimental Therapeutics


Head & Neck


Soft Tissue


Ocular



Genitourinary


Thoracic


Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma: A Single Institution Study

Tourkantonis, Ioannis; Makrilia, Nektaria; Ralli, Maria; More

American Journal of Clinical Oncology. 34(1):38-42, February 2011.

Gastrointestinal


Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer: A Phase II Study

Safran, Howard; Miner, Thomas; Bahary, Nathan; More

American Journal of Clinical Oncology. 34(1):50-52, February 2011.

Phase I/II Study of Hepatic Arterial Infusion Chemotherapy With Gemcitabine in Patients With Unresectable Intrahepatic Cholangiocarcinoma (JIVROSG-0301)

Inaba, Yoshitaka; Arai, Yasuaki; Yamaura, Hidekazu; More

American Journal of Clinical Oncology. 34(1):58-62, February 2011.

Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma

Astsaturov, Igor A.; Meropol, Neal J.; Alpaugh, R. Katherine; More

American Journal of Clinical Oncology. 34(1):70-75, February 2011.


Expert Opinions of the First Italian Consensus Conference on the Management of Malignant Pleural Mesothelioma

Pinto, Carmine; Ardizzoni, Andrea; Betta, Pier Giacomo; More

American Journal of Clinical Oncology. 34(1):99-109, February 2011.